Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.38% | 6.12% | 15.71% | 36.25% | 35.06% |
| Total Receivables | 8.66% | 0.19% | -3.68% | -21.31% | -18.13% |
| Inventory | -34.22% | -34.41% | -35.14% | 474.24% | -56.62% |
| Prepaid Expenses | -47.24% | -35.82% | 6.57% | -0.25% | 18.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -11.53% | -12.76% | -2.24% | -10.28% | -13.44% |
|
|
|||||
| Total Current Assets | -11.53% | -12.76% | -2.24% | -10.28% | -13.44% |
| Net Property, Plant & Equipment | -89.36% | -85.66% | -82.21% | -73.31% | -60.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -10.74% | -17.47% | -16.63% | -22.99% | -22.26% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -56.10% | -56.32% | -86.57% | -1.33% | -68.57% |
| Total Assets | -36.07% | -39.14% | -44.81% | -42.37% | -39.16% |
|
|
|||||
| Total Accounts Payable | 55.36% | -10.72% | 2.21% | 7.42% | 49.15% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -53.95% | -54.95% | -58.11% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.10% | 32.25% | -78.59% | -40.00% | -40.58% |
| Total Finance Division Other Current Liabilities | 5.19% | 4.75% | 3.84% | -86.44% | -84.17% |
| Total Other Current Liabilities | 5.19% | 4.75% | 3.84% | -86.44% | -84.17% |
| Total Current Liabilities | -33.79% | -36.85% | -40.88% | -43.08% | 27.15% |
|
|
|||||
| Total Current Liabilities | -33.79% | -36.85% | -40.88% | -43.08% | 27.15% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -53.95% | -54.95% | -58.11% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -96.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -33.89% | -37.26% | -42.24% | -45.58% | 21.29% |
|
|
|||||
| Common Stock & APIC | 81.37% | 81.37% | 81.37% | 81.37% | 0.00% |
| Retained Earnings | -12.74% | -12.91% | -16.20% | -17.38% | -26.54% |
| Treasury Stock & Other | -100.60% | -76.17% | 15.04% | 34.12% | 37.90% |
| Total Common Equity | 34.44% | 37.39% | 42.92% | 46.88% | -58.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.44% | 37.39% | 42.92% | 46.88% | -58.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -276.76% | -151.95% | -91.72% | -31.38% | -81.93% |
| Total Equity | 33.31% | 36.66% | 41.04% | 47.33% | -64.46% |
|
|
|||||